Search | German Center for Infection Research

How resistant is the Omikron variant to current antibodies?

Cell culture studies show SARS-CoV-2 variant Omicron evades antibodies generated after infection and vaccination and is resistant to several therapeutic antibodies. In contrast, antibodies induced

A medication against Covid-19 in development

Vaccines against the SARS-CoV-2 virus have been made possible by an unprecedented worldwide collaboration. But medications against Covid-19 have as yet seen only partial success. A Munich research

Oct 2021

PLoS Negl Trop Dis

Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon

Autoren

Mouwenda YD et al.

Sep 2021

Front Immunol

Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24(high)CD38(high) Regulatory B Cells and Lower Levels of IL-10 Expression Compared to Responders

Autoren

Körber N et al.

Oct 2021

Vaccines (Basel)

Characterization of Individuals Interested in Participating in a Phase I SARS-CoV-2 Vaccine Trial

Autoren

Shamsrizi P et al.

Oct 2021

Int J Hyg Environ Health

Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic

Autoren

Brehm TT et al.

Oct 2021

Internist

[Vaccines against COVID-19]

Autoren

Fathi A

Mellinghoff SC

Sep 2021

Blood

Insights in ChAdOx1 nCov-19 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)

Autoren

Greinacher A et al.

Ulrike Protzer is awarded the DZIF Prize for Translational Infection Research

This year, the German Center for Infection Research (DZIF) is honouring the medical scientist and clinical virologist Prof. Ulrike Protzer for her scientific achievements. The prize is endowed with

Bonn - Köln

Antibacterial Vaccines and Diagnostics Development (ACTIVATE)

The DZIF working group "Antibacterial Vaccines and Diagnostics Development" (ACTIVATE) led by Alexander Klimka develops active and passive vaccines against bacterial pathogens and antibody-based rapid tests to detect antibiotic-resistant bacteria. In 2017, the World Health Organization (WHO) ...